{'fraction_non_alphanumeric': 0.025142857142857144, 'fraction_numerical': 0.008, 'mean_word_length': 4.651612903225806, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Efficacy and Safety of Maintenance ECT in Geriatric Patients

lectroconvulsive therapy (ECT) is commonly prescribed for older patients. After acute treatment E with ECT, some patients are continued in maintenance ECT (M-ECT) treatment because of drug refractoriness or inability to tolerate drug side effects. Some M-ECT patients are in partial or full remission from their depressive illness and receive ECT once or twice a month to prevent relapse or recurrence. Most M-ECT’-9 studies have not specifically addressed the issue of efficacy and safety in patients over 75 years of age. We havP previously reported on the efficacy and safety of M-ECT in an older (average age 68 years) population.’ Here we present data on the eight patients over the age of 75 from this earlier study who were successfully and safely treated with M-ECT. Four cases are reported in detail.